These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 138495)

  • 21. [Rhus dermatitis or poison ivy dermatitis in Lorraine].
    Beurey J; Mougeolle JM; Weber M; Mazet J
    Ann Dermatol Venereol; 1980; 107(1-2):65-7. PubMed ID: 6445173
    [No Abstract]   [Full Text] [Related]  

  • 22. A murine model system for contact sensitization to poison oak or ivy urushiol components.
    Dunn IS; Liberato DJ; Dennick RG; Castagnoli N; Byers VS
    Cell Immunol; 1982 Apr; 68(2):377-88. PubMed ID: 6178516
    [No Abstract]   [Full Text] [Related]  

  • 23. The poison ivy picker of Pennypack Park: the continuing saga of poison ivy.
    Epstein WL
    J Invest Dermatol; 1987 Mar; 88(3 Suppl):7s-11s. PubMed ID: 2950182
    [No Abstract]   [Full Text] [Related]  

  • 24. Poison ivy/oak dermatitis. Part I: Prevention--soap and water, topical barriers, hyposensitization.
    Fisher AA
    Cutis; 1996 Jun; 57(6):384-6. PubMed ID: 8804839
    [No Abstract]   [Full Text] [Related]  

  • 25. GLC analysis of poison ivy and poison oak urushiol components in vegetable oil preparations.
    Elsohly MA; Turner CE
    J Pharm Sci; 1980 May; 69(5):587-9. PubMed ID: 7381750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New GLC analysis of urushiol congeners in different plant parts of poison ivy, Toxicodendron radicans.
    Craig JC; Waller CW; Billets S; Elsohly MA
    J Pharm Sci; 1978 Apr; 67(4):483-5. PubMed ID: 641754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of poison ivy/oak allergic contact dermatitis with an extract of jewelweed.
    Long D; Ballentine NH; Marks JG
    Am J Contact Dermat; 1997 Sep; 8(3):150-3. PubMed ID: 9249283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Allergic contact dermatitis to common ivy (Hedera helix L.)].
    Ozdemir C; Schneider LA; Hinrichs R; Staib G; Weber L; Weiss JM; Scharffetter-Kochanek K
    Hautarzt; 2003 Oct; 54(10):966-9. PubMed ID: 14513244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poison ivy, oak, and sumac dermatitis identification, treatment, and prevention.
    Garner LA
    Phys Sportsmed; 1999 May; 27(5):33-43. PubMed ID: 20086717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urushiol Compounds Detected in Toxicodendron-Labeled Consumer Products Using Mass Spectrometry.
    Zhang AJ; Aschenbeck KA; Law BF; BʼHymer C; Siegel PD; Hylwa SA
    Dermatitis; 2020; 31(2):134-139. PubMed ID: 32168145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermatitis from cashew nuts.
    Marks JG; DeMelfi T; McCarthy MA; Witte EJ; Castagnoli N; Epstein WL; Aber RC
    J Am Acad Dermatol; 1984 Apr; 10(4):627-31. PubMed ID: 6715612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of 42 microsatellite markers from poison ivy, Toxicodendron radicans (Anacardiaceae).
    Hsu TW; Shih HC; Kuo CC; Chiang TY; Chiang YC
    Int J Mol Sci; 2013 Oct; 14(10):20414-26. PubMed ID: 24129176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quantitative study of the relation of synthetic 3-pentadecyl catechol to hypersensitiveness to Rhus toxicodendron (poison ivy) as shown by the patch test.
    KEIL H; WASSERMAN D; DAWSON CR
    J Allergy; 1945; 16():275-9. PubMed ID: 21006656
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification and treatment of poison ivy dermatitis.
    Briant D; Brouder G
    Nurse Pract; 1983; 8(7):13, 16, 19 passim. PubMed ID: 6225038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ON THE ISOLATION OF THE ALLERGENICALLY ACTIVE COMPONENTS OF THE TOXIC PRINCIPLE OF POISON IVY.
    MARKIEWITZ KH; DAWSON CR
    J Org Chem; 1965 May; 30():1610-3. PubMed ID: 14290380
    [No Abstract]   [Full Text] [Related]  

  • 36. Poison ivy/oak/sumac. Part II: Specific features.
    Fisher AA
    Cutis; 1996 Jul; 58(1):22-4. PubMed ID: 8823544
    [No Abstract]   [Full Text] [Related]  

  • 37. Toxicodendron Contact Dermatitis: A Case Report and Brief Review.
    Monroe J
    J Clin Aesthet Dermatol; 2020 Sep; 13(9 Suppl 1):S29-S34. PubMed ID: 33349791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed contact sensitivity to catechols. II. Cutaneous toxicity of catechols chemically related to the active principles of poison ivy.
    Baer H; Watkins RC; Kurtz AP; Byck JS; Dawson CR
    J Immunol; 1967 Aug; 99(2):365-9. PubMed ID: 4226615
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemical and biological tests with the toxic substance of poison ivy (urushiol) and its absorption by amberlite ion exchange resins.
    THURMON FM; OTTENSTEIN B; BESSMAN MJ
    J Invest Dermatol; 1955 Jul; 25(1):9-20. PubMed ID: 13242899
    [No Abstract]   [Full Text] [Related]  

  • 40. MALDI-MS Imaging of Urushiols in Poison Ivy Stem.
    Aziz M; Sturtevant D; Winston J; Collakova E; Jelesko JG; Chapman KD
    Molecules; 2017 Apr; 22(5):. PubMed ID: 28468273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.